Muscle Cell News Volume 6.36 | Oct 25 2021

    0
    41






    2021-10-25 | MUSCN 6.36


    Muscle Cell News by STEMCELL Technologies
    Vol. 6.36 – 25 October, 2021
    TOP STORY

    Physiologic Biomechanics Enhance Reproducible Contractile Development in a Stem Cell Derived Cardiac Muscle Platform

    Researchers developed a platform of micron-scale cardiac muscle bundles to control biomechanics in arrays of thousands of purified, independently contracting cardiac muscle strips on two-dimensional elastomer substrates with far greater throughput than single cell methods.
    [Nature Communications]

    Full Article

    Virtual Conference Exhibition: Pluripotent Stem Cells
    PUBLICATIONSRanked by the impact factor of the journal

    Functional Effects of Cardiomyocyte Injury in COVID-19

    Scientists infected human induced pluripotent stem cells-derived cardiomyocytes, from healthy human subjects, with SARS-CoV-2 in the absence and presence of IL-6 and IL-1β. Infection resulted in increased numbers of multinucleated cells.
    [Journal of Virology]

    Abstract

    Fortilin Inhibits p53, Halts Cardiomyocyte Apoptosis, and Protects the Heart against Heart Failure

    Researchers demonstrated that fortilin sustained cardiomyocyte survival at least partly through inhibition of p53 and p53-dependent apoptosis.
    [Cell Death Discovery]

    Full Article

    Circular RNA hsa_circ_105039 Promotes Cardiomyocyte Differentiation by Sponging miR-17 to Regulate cyclinD2 Expression

    hsa_circ_105039 was underexpressed in the heart tissue of patients with congenital heart disease. Investigators found that hsa_circ_105039 overexpression promoted cell differentiation, viability and migration; whereas apoptosis was simultaneously repressed.
    [Molecular Medicine Reports]

    Abstract

    LncRNA TUG1 Aggravates Cardiomyocyte Apoptosis and Myocardial Ischemia/Reperfusion Injury

    Researchers reported that TUG1 expression was induced in mouse heart following myocardial ischemia/reperfusion injury as well as in cardiomyocytes subjected to simulated ischemia/reperfusion in vitro.
    [Histology and Histopathology]

    Abstract

    Human Skeletal Muscle CD90+ Fibro-Adipogenic Progenitors Are Associated with Muscle Degeneration in Type 2 Diabetic Patients

    The authors showed that skeletal muscle of type 2 diabetes mellitus patients exhibited degenerative remodeling of the ECM that was associated with a selective increase of a subpopulation of fibro-adipogenic progenitors (FAPs) marked by expression of THY1 (CD90)—the FAPCD90+.
    [Cell Metabolism]

    AbstractGraphical Abstract

    Cavin4 Interacts with Bin1 to Promote T-tubule Formation and Stability in Developing Skeletal Muscle

    Scientists identified a role for the muscle-specific component, Cavin4, in skeletal muscle T-tubule development by analyzing two vertebrate systems, mouse and zebrafish.
    [Journal of Cell Biology]

    Full Article

    CircSOD2: A Novel Regulator for Smooth Muscle Proliferation and Neointima Formation

    Researchers investigated the role and mechanism of circSOD2 in smooth muscle cell proliferation and neointima formation.
    [Arteriosclerosis Thrombosis and Vascular Biology]

    Abstract

    Smooth Muscle 22 Alpha Protein Inhibits VSMC Foam Cell Formation by Supporting Normal LXRα Signaling, Ameliorating Atherosclerosis

    The authors found a potential association between the deletion of smooth muscle 22α and deregulated nuclear receptors liver X receptors /retinoid X receptor signaling in mice.
    [Cell Death & Disease]

    Full Article

    Peroxisome Proliferator-Activated Receptor β/δ Regulates Cerebral Vasospasm after Subarachnoid Hemorrhage via Modulating Vascular Smooth Muscle Cells Phenotypic Conversion

    Subarachnoid hemorrhage grade, neurological scores, brain water content and brain swelling were measured to study the mechanisms of PPARβ/δ on vascular smooth muscle phenotypic transformation.
    [Molecular Medicine Reports]

    Abstract

    Tools and products for your COVID-19 research.
    REVIEWS

    A Framework for Developing Sex-Specific Engineered Heart Models

    Investigators analyze sex-related properties of the heart muscle in the context of health and disease, and discuss a framework for including sex-based differences in human cardiac tissue engineering.
    [Nature Reviews Materials]

    Full Article

    INDUSTRY AND POLICY NEWS

    CANbridge Pharmaceuticals Enters into Exclusive Worldwide Research Collaboration and Licensing Agreement with Scriptr Global for Stitchrâ„¢ RNA Assembly Technology to Develop Gene Therapy Product Targeting Dystrophinopathies

    CANbridge Pharmaceuticals, Inc. announced that it has entered into a research collaboration and license agreement with Scriptr Global, Inc., for the development of a gene therapy treatment targeting dystrophinopathies.
    [CANbridge Pharmaceuticals, Inc.]

    Press Release

    FEATURED EVENT

    Applying Fundamental Principles of Lung Biology to Respiratory Health

    November 6 – 7, 2021
    Waterville Valley, New Hampshire, United States

    > See All Events

    JOB OPPORTUNITIES

    Research Associate I – Histology & Morphometrics

    Sarepta Therapeutics Inc. – Columbus, Ohio, United States

    Research Assistant I – Skeletal Muscle

    Baylor College of Medicine – Houston, Texas, United States

    PhD Student – Cardiovascular Disease

    Radboud University Medical Centre – Nijmegen, Netherlands

    Assistant Professor – Pediatric Heart Disease

    Harvard Medical School – Boston, Massachusetts, United States

    Postdoctoral Associate – Cardiovascular Biology and Disease Modeling

    Sanford Burnham Prebys Medical Discovery Institute – San Diego, California, United States

    > See All Jobs

    Submit (1)
    Brought to you by
    stemcell-logo-for newsletter-2
    Muscle Cell News Twitter